HPV Trials: No True Placebo? Gøtzsche Review Flags High Bias + Underreported Harms (Tomljenović)

Donate : 🙏 https://www.buymeacoffee.com/slobodnipoI Tomljenović turns from observational data to the part people assume is “settled”: randomized controlled trials. She argues the key issue is trial quality and independence: she notes that HPV vaccine RCTs were run by manufacturers, and she cites reviews (including work associated with Peter Gøtzsche) that rated the trials as high risk of bias. One major claim she highlights is that many studies did not use an inert placebo, but used adjuvants/active comparators labeled as “placebo.” She also stresses a second problem: the trials were designed mainly around surrogate endpoints (precancerous lesions), with limited follow-up — so she argues the long-term “prevents cancer” narrative is being treated as proven when the underlying evidence is more indirect than most people realize. Full episode: https://www.youtube.com/playlist?list=PLJTy3oXCzHShsVuJ-zfiGnx96nuR-BNWB WEB: https://slobodnipodcast.hr/?p=1402